Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Recursion Pharmaceuticals LLC
Nvidia’s AI ambitions in medicine and health care are becoming clear
Applying Nvidia AI chips to health care, whether it's biotechnology, chemicals, or drug discovery is going to be a big
Read More
Hedge funds are betting big against these stocks and it’s working
The latest short interest data reveals several stocks that are down both month to date and since the start of
Read More
Nvidia holdings disclosure pumps up shares of small AI companies
A filing from Nvidia late Wednesday shows the chipmaker has stakes in a handful of public companies. Source link
Read More
Top Wall Street analysts pick these stocks for solid returns
Here are the biggest calls on Wall Street on Source link
Read More
Forget Big Tech? Fund manager names 6 lesser-known tech stocks to buy instead
It's time to get constructive on mid-cap tech stocks, according to Karen Kharmandarian, senior portfolio manager at Thematics Asset Management.
Read More
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read More
Artificial intelligence drug hunters are nearing a pivotal stage in their development
Over the next 12 to 18 months, AI-first drug developers will provide updates on early clinical work that will help
Read More